| Literature DB >> 20631381 |
Enrico Lugli1, Carolyn K Goldman, Liyanage P Perera, Jeremy Smedley, Rhonda Pung, Jason L Yovandich, Stephen P Creekmore, Thomas A Waldmann, Mario Roederer.
Abstract
Interleukin-15 (IL-15) is a cytokine with potential therapeutic application in individuals with cancer or immunodeficiency to promote natural killer (NK)- and T-cell activation and proliferation or in vaccination protocols to generate long-lived memory T cells. Here we report that 10-50 μg/kg IL-15 administered intravenously daily for 12 days to rhesus macaques has both short- and long-lasting effects on T-cell homeostasis. Peripheral blood lymphopenia preceded a dramatic expansion of NK cells and memory CD8 T cells in the circulation, particularly a 4-fold expansion of central memory CD8 T cells and a 6-fold expansion of effector memory CD8 T cells. This expansion is a consequence of their activation in multiple tissues. A concomitant inverted CD4/CD8 T-cell ratio was observed throughout the body at day 13, a result of preferential CD8 expansion. Expanded T- and NK-cell populations declined in the blood soon after IL-15 was stopped, suggesting migration to extralymphoid sites. By day 48, homeostasis appears restored throughout the body, with the exception of the maintenance of an inverted CD4/CD8 ratio in lymph nodes. Thus, IL-15 generates a dramatic expansion of short-lived memory CD8 T cells and NK cells in immunocompetent macaques and has long-term effects on the balance of CD4(+) and CD8(+) T cells.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20631381 PMCID: PMC2995354 DOI: 10.1182/blood-2010-03-275438
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113